(Q37320550)

English

Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus

scientific article published on 02 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

19 August 2017

systemic lupus erythematosus

0 references

4

object named as

Zahir Amoura

1 reference

Europe PubMed Central

19 August 2017

author name string

Andrew A Welcher

1

1 reference

Europe PubMed Central

19 August 2017

Michael Boedigheimer

2

1 reference

Europe PubMed Central

19 August 2017

Alan J Kivitz

3

1 reference

Europe PubMed Central

19 August 2017

Jill Buyon

5

1 reference

Europe PubMed Central

19 August 2017

Alla Rudinskaya

6

1 reference

Europe PubMed Central

19 August 2017

Kevin Latinis

7

1 reference

Europe PubMed Central

19 August 2017

Kit Chiu

8

1 reference

Europe PubMed Central

19 August 2017

Kelly S Oliner

9

1 reference

Europe PubMed Central

19 August 2017

Michael A Damore

10

1 reference

Europe PubMed Central

19 August 2017

Gregory E Arnold

11

1 reference

Europe PubMed Central

19 August 2017

Winnie Sohn

12

1 reference

Europe PubMed Central

19 August 2017

Narendra Chirmule

13

1 reference

Europe PubMed Central

19 August 2017

Lovely Goyal

14

1 reference

Europe PubMed Central

19 August 2017

Christopher Banfield

15

1 reference

Europe PubMed Central

19 August 2017

James B Chung

16

1 reference

Europe PubMed Central

19 August 2017

publication date

2 July 2015

1 reference

Europe PubMed Central

19 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

19 August 2017

67

1 reference

Europe PubMed Central

19 August 2017

10

1 reference

Europe PubMed Central

19 August 2017

2713-2722

1 reference

Europe PubMed Central

19 August 2017

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Statistical tests for differential expression in cDNA microarray experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Roles of interferon-gamma and interleukin-4 in murine lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

6 September 2017

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

Systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

Combined oral contraceptives in women with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5054935

2 September 2018

A direct approach to false discovery rates

1 reference

https://api.crossref.org/works/10.1002%2FART.39248

21 January 2018

SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1002%2FART.39248

21 January 2018

Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.39248

21 January 2018

Type I IFN protects against murine lupus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum level of interferon-gamma in autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/26138472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.39248

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37320550&oldid=2098939397"